One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

Ontario to curb prosecution of HIV non-disclosure cases - picture 1

Ontario to curb prosecution of HIV non-disclosure cases

6 December 2017, 14:46 contact@life4me.plus

The Ontario government announced that Crown attorneys will no longer prosecute cases of HIV-positive people who don’t disclose their status to their sexual partner when the person who is HIV-positive has had a suppressed viral load for six months, The Star reports.

The announcement was a response to the federal justice department’s report titled “Criminal Justice System’s Response to Non-Disclosure of HIV,” released last week.

The report, backed by analysis from the Public Health Agency of Canada, concludes that the criminal law should generally not apply to people who are on HIV treatment (which suppresses their viral load and makes transmission unlikely), are not on treatment, but use condoms, or engage only in oral sex.

“The realistic possibility of a transmission test is likely not met in these circumstances,” the report concludes.

The federal report recognized that HIV “is first and foremost a public health issue,” and concluded that non-disclosure prosecutions disproportionately affect people who are Indigenous, gay and Black.


Latest News

All news - picture 2

Chemsex is associated with an increased risk of HIV transmission and sexual infections

The use of gay, bisexual and other men who have sex with men (#MSM), crystallized methamphetamine, mephedrone, γ-hydroxybutyrate or γ-butyrolactone, and to a lesser extent cocaine and ketamine during sexual intercourse, or the so-called " the phenomenon is relatively new, ...

23 May 15:48

All news - picture 3

ART drug Juluca appears in European pharmacies

Pharmaceutical company ViiV Healthcare, specializing in the development and production of medicines for HIV treatment, reported that the European Commission issued a permit for the implementation in Europe of the combined drug Juluca (#dolutegravir 50 mg / rilpivirine 25 ...

22 May 14:30

All news - picture 4

Truvada in the US will be used to reduce the risk of HIV transmission among adolescents

Gilead Sciences, Inc. announced that the FDA approved once-daily oral emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (Truvada) in combination with safe sex practices, to reduce the risk of sexually acquired HIV-1 in at-risk adolescents.

17 May 15:01

All news - picture 5

A patient has died from AIDS in Switzerland because he was not paid for HIV treatment

As it became known to the media, an HIV-positive patient died from AIDS in Switzerland in the end of 2017. He was being refused of a medical treatment due to missing necessary health insurance, and the insurance company refused several times to pay for the treatment because ...

1 May 14:29